en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
6/2005
vol. 43
 
Share:
Share:
more
 
 
abstract:

ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPER
Usefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences

Lidia Ostanek
,
Marek Brzosko
,
Katarzyna Fischer

Ru 2005; 43, 6: 354-357
Online publish date: 2005/12/22
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The presence of anticardiolipin antibodies (aCL) and lupus anticoagulant (LA) is considered among diagnostic criteria of antiphospholipid syndrome (APS). Studies during the last decade revealed that also other antibodies, mainly antiprothrombin antibodies and anti-b22-glycoprotein I (ab2GPI), belong to antiphospholipid antibodies, which play significant role in the developing of APS. The review of papers on incidence and clinical significance of the antibodies, as well as own experiences are presented.
keywords:

antiphospholipid syndrome, systemic lupus erythematosus, anticardiolipin antibodies, antiprothrombin antibodies, anti-b2GPI antibodies







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.